HomeWebcastChemical & Life Sciences Patents: A Look Back and A Sneak Peek to the Future
Online CLE Life Sciences CLE

Chemical & Life Sciences Patents: A Look Back and A Sneak Peek to the Future

Live Webcast Date: Thursday, October 11, 2018 from 3:00 pm to 4:00 pm (ET)
Intellectual Property Law (CLE)Pharmaceutical & Life Sciences CLE & CPERecording

Online CLE Life Sciences

Join us for this Knowledge Group Online CLE Life Sciences Webinar. Fiscal year 2017 brought sweeping innovations and developments in the chemical and life sciences patents sector. Of notable significance is the surge of patent applications for nanotechnology and artificial intelligence software as medical device, thus, introducing certain intellectual property (IP) challenges. In addition, five major Supreme Court decisions paved the way for important patent jurisprudence updates which are expected to affect impending applications and cases.

Following these developments, it is imperative for chemical and life sciences-related professionals to be well versed of the recent and upcoming changes. Devising a strategic monitoring program to map out future course of action is critical.

In this Webcast, a panel of key thought leaders organized by The Knowledge Group will provide the audience with an overview of chemical and life sciences patent updates in 2018. Speakers, among other things, will offer helpful insights on the significant effects of last year's developments on upcoming cases. They will also provide the audience with practical tips in devising a comprehensive program that will monitor significant changes.

Key topics include:

  • A Look Back at 2017 Developments
  • The Chemical and Life Sciences Patents in 2018
  • 2018 Patent Applications and Cases
  • Updates in Artificial Intelligence Software and Nanotechnology
  • Practical Tips and Strategies

Agenda

SEGMENT 1:
Keith D. FredlakePartner
Kilpatrick Townsend & Stockton LLP

  • patent eligibility – Vanda memo
  • patent indefiniteness – Teva, Nautilus
  • AIA – on sale bar – Helsinn
  • Markush claims - Shire Dev

SEGMENT 2:
Dean L. Fanelli, Ph.D.Partner
Seyfarth Shaw LLP

Patent Eligibility

  • Vanda memo
  • CRISPRS
  • License development
  • Bioinformatics

Who Should Attend

  • Chemical and Life Sciences Companies
  • Patent Licensing Attorneys
  • In-house Counsel
  • Patent Owners and Inventors
  • Drug Manufacturing Executives
  • Executives coming from Biotech Companies
  • Patent Litigators and Consultants
  • Other Related and Interested Professionals

Online CLE Life Sciences

SEGMENT 1:
Keith D. FredlakePartner
Kilpatrick Townsend & Stockton LLP

  • patent eligibility – Vanda memo
  • patent indefiniteness – Teva, Nautilus
  • AIA – on sale bar – Helsinn
  • Markush claims - Shire Dev

SEGMENT 2:
Dean L. Fanelli, Ph.D.Partner
Seyfarth Shaw LLP

Patent Eligibility

  • Vanda memo
  • CRISPRS
  • License development
  • Bioinformatics

Online CLE Life Sciences

Online CLE Life Sciences

Dean L. Fanelli, Ph.D.PartnerSeyfarth Shaw LLP

Dean L. Fanelli, Ph.D. is a partner in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. Dr. Fanelli’s expertise lies in patent portfolio creation and management, counseling, technology transactions, due diligence, opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions, and inter partes review and post grant review proceedings.  Dr. Fanelli also has significant experience with the interplay between patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, and financing for life sciences companies as well as ANDA analyses associated with Hatch-Waxman paragraph IV litigation.

Dr. Fanelli received his J.D. from The George Washington University Law School and received his Ph.D. in organic chemistry from Temple University, where he studied the syntheses of biologically active amino acids and amino acid derivatives under the supervision of Dr. Franklin A. Davis.

Online CLE Life Sciences

Keith D. FredlakePartnerKilpatrick Townsend & Stockton LLP

Keith Fredlake is a registered patent attorney who focuses his practice on intellectual property matters, including drafting and prosecuting patent applications, primarily in the chemical and life sciences industry including chemistry, chemical engineering, oil & gas-petrochemicals, medical devices and pharmaceuticals. Mr. Fredlake works with clients on design patents and he also counsels clients on issues regarding the patentability of inventions, patent rights in foreign countries, and the infringement and validity of U.S. patents.

Mr. Fredlake’s patent practice includes performing portfolio review for clients, including freedom-to-operate, invalidity, patentability and opposition searches. He is also experienced in the preparation of invalidity and non-infringement options for utility and design patents.


Click Here to Read Additional Material

Online CLE Life Sciences

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   Experience in intellectual property law

Course Code:
   147373

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credit:
    1.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Seyfarth Shaw LLP has more than 850 attorneys and provides a broad range of legal services in the areas of intellectual property, labor and employment, employee benefits, litigation, corporate and real estate. With offices in Atlanta, Boston, Chicago, Houston, London, Los Angeles, Melbourne, New York, Sacramento, San Francisco, Shanghai, Sydney and Washington, D.C., Seyfarth’s clients include over 300 of the Fortune 500 companies and reflect virtually every industry and segment of the economy. A recognized leader in delivering value and innovation for legal services, Seyfarth’s acclaimed SeyfarthLean client service model has earned numerous accolades from a variety of highly respected third parties, including industry associations, consulting firms and media. For more information, please visit www.seyfarth.com.

Website: https://www.seyfarth.com/

Kilpatrick Townsend has over two hundred lawyers in the patent field covering a wide range of technologies and industries. Our record of helping our clients grow and protect innovative businesses and products has been recognized repeatedly:

  • Tier 1: US News - Best Lawyers® 2016 “Best Law Firms” Rankings for Patent Law and Litigation – Intellectual Property.
  • The Best Lawyers in America®; top-listed in the nation for Patent Law and Litigation – Intellectual Property.
  • IAM Patent 1000 - The World’s Leading Patent Practitioners:  highest National ranking in Patent Prosecution.
  • “U.S. Patent Prosecution Firm of the Year” (Managing Intellectual Property 2013).

Kilpatrick Townsend has a deep and diverse patent bench brings to bear a wide range of experience and specialized knowledge to patent matters. Our competitive advantage is derived from our comprehensive understanding of technology and of the law. For example:

  • More than 200 Kilpatrick Townsend lawyers and patent agents are registered to practice before the United States Patent and Trademark Office.
  • Our lawyers hold scientific and engineering degrees in virtually every technical discipline, ranging from electronics to the life sciences.
  • More than 50 of our patent lawyers hold PhDs in their fields, and nearly 100 of our attorneys and technical and scientific staff have master’s degrees.
  • Our patent group includes former engineers, scientists, patent examiners and federal law clerks.
  • Our patent prosecution practice is organized into three main technology teams:
  • Chemistry and Life Sciences
  • Mechanical Engineering and Medical Devices
  • Electronic Engineering and Software
  • Our technology teams meet regularly to stay abreast of relevant developments in their area and discuss strategies for improving prosecution skills and practices. 

In short, there is rarely an occasion where a client approaches us with technology not familiar to someone within our patent practice.

Website: https://www.kilpatricktownsend.com/

Dean L. Fanelli, Ph.D. is a partner in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. Dr. Fanelli’s expertise lies in patent portfolio creation and management, counseling, technology transactions, due diligence, opinion work, including drafting novelty, freedom-to-operate, and invalidity opinions, and inter partes review and post grant review proceedings.  Dr. Fanelli also has significant experience with the interplay between patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, and financing for life sciences companies as well as ANDA analyses associated with Hatch-Waxman paragraph IV litigation.

Dr. Fanelli received his J.D. from The George Washington University Law School and received his Ph.D. in organic chemistry from Temple University, where he studied the syntheses of biologically active amino acids and amino acid derivatives under the supervision of Dr. Franklin A. Davis.

Keith Fredlake is a registered patent attorney who focuses his practice on intellectual property matters, including drafting and prosecuting patent applications, primarily in the chemical and life sciences industry including chemistry, chemical engineering, oil & gas-petrochemicals, medical devices and pharmaceuticals. Mr. Fredlake works with clients on design patents and he also counsels clients on issues regarding the patentability of inventions, patent rights in foreign countries, and the infringement and validity of U.S. patents.

Mr. Fredlake’s patent practice includes performing portfolio review for clients, including freedom-to-operate, invalidity, patentability and opposition searches. He is also experienced in the preparation of invalidity and non-infringement options for utility and design patents.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199